STOCK TITAN

BioLife Solutions to Report Fourth Quarter and Full Year 2023 Financial Results and Business Update on February 29, 2024

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary
BioLife Solutions, Inc. (NASDAQ: BLFS) announced the release of its fourth-quarter and full-year 2023 financial results on February 29, 2024. The Company will conduct a conference call and webcast to discuss the financial results and provide a business update.
Positive
  • None.
Negative
  • None.

BOTHELL, Wash., Feb. 20, 2024 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies ("CGT") and broader biopharma markets, today announced the Company's fourth quarter and full year 2023 financial results will be released after market close on Thursday, February 29, 2024. The Company will host a conference call and live webcast at 4:30pm ET (1:30pm PT) that day. Management will provide an overview of the Company's financial results and give a general business update.

To access the webcast, log onto the Investor Relations page of the BioLife Solutions website at https://www.biolifesolutions.com/earnings. In addition, the conference call will be accessible by dialing toll-free 1-833-630-0431 or 1-412-317-1808 for international callers. The conference ID number is 29175. A webcast replay will be available approximately two hours after the call and will be archived on https://investors.biolifesolutions.com for 90 days. If you would like to pre-register for this call, please use this pre-registration link.

About BioLife Solutions

BioLife Solutions is a leading supplier of class-defining bioproduction tools and services for the cell and gene therapy (CGT) and broader biopharma markets. Our expertise facilitates the commercialization of new therapies by supplying solutions that maintain the health and function of biologic materials during collection, development, storage, and distribution. For more information, please visit www.biolifesolutions.com or follow BioLife on LinkedIn and X.

 

Media & Investor Relations

At the Company
Troy Wichterman
Chief Financial Officer
(425) 402-1400
twichterman@biolifesolutions.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/biolife-solutions-to-report-fourth-quarter-and-full-year-2023-financial-results-and-business-update-on-february-29-2024-302064629.html

SOURCE BioLife Solutions, Inc.

FAQ

When will BioLife Solutions release its fourth quarter and full-year 2023 financial results?

BioLife Solutions will release its fourth quarter and full-year 2023 financial results after market close on Thursday, February 29, 2024.

How can I access the webcast of the financial results discussion?

To access the webcast, you can log onto the Investor Relations page of the BioLife Solutions website at https://www.biolifesolutions.com/earnings.

What is the conference call schedule for discussing the financial results?

The conference call and live webcast will be held at 4:30pm ET (1:30pm PT) on the same day the financial results are released.

How can I participate in the conference call?

You can participate in the conference call by dialing toll-free 1-833-630-0431 or 1-412-317-1808 for international callers. The conference ID number is 29175.

Will there be a replay of the webcast available?

Yes, a webcast replay will be available approximately two hours after the call and will be archived on https://investors.biolifesolutions.com for 90 days.

Is there a pre-registration link available for the conference call?

Yes, you can pre-register for the conference call using the provided pre-registration link.

BioLife Solutions Inc.

NASDAQ:BLFS

BLFS Rankings

BLFS Latest News

BLFS Stock Data

816.76M
32.61M
3.56%
102.15%
7.06%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States of America
BOTHELL

About BLFS

bothell, wa-based biolife solutions, inc. (nasdaq: blfs), is a leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud hosted biologistics cold chain management app for smart shippers.